(Q28192543)

3

object named as

Truls Ostbye

0 references

author name string

Elizabeth R DeLong

2

0 references

Lawrence H Muhlbaier

4

0 references

Anita Chen

5

0 references

Nancy Allen LaPointe

6

0 references

Bradley G Hammill

7

0 references

Charles B McCants

8

0 references

Judith M Kramer

American Journal of Cardiology

9

0 references

language of work or name

English

0 references

publication date

15 March 2002

0 references

published in

0 references

volume

89

0 references

issue

6

0 references

page(s)

653-61

0 references

cites work

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Early and pre-discharge aspirin administration among patients with acute myocardial infarction: current clinical practice and trends in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Aspirin use is low among United States outpatients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Rating the appropriateness of coronary angiography--do practicing physicians agree with an expert panel and with each other?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Is aspirin safe for patients with heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902335-9